ESOI - European Society of Oncologic Imaging

ESOI - European Society of Oncologic Imaging A non-profit organization dedicated to advancing and coordinating scientific activities in Oncologic Imaging

The European Society of Oncologic Imaging is an apolitical, non-profit organisation, exclusively and directly dedicated to promoting and coordinating the scientific, philanthropic, intellectual and professional activities of Oncologic Imaging. The Society’s mission at all times is to serve the health care needs of the general public through the support of science, teaching and research and the quality of service in the field of Oncologic Imaging. The European Society of Oncologic Imaging will set its focus on establishing Oncologic Imaging (OI) as an area of special interest and expertise in the field of diagnostic and interventional radiology with the European Society of Radiology (ESR) and particularly with all established committees of ESR in order to provide both a scientific forum and to promote research as well as technical developments in Oncologic Imaging in Europe. Through dissemination of knowledge and research information, in particular across Europe, the European Society of Oncologic Imaging aims to advance and improve all radiological aspects of patients with malignancy, the quality of diagnosis and treatment of oncologic patients by means of medical imaging.

It is a busy season for ESOI President Melvin D'Anastasi, ESOI Membership Committee Chair Damiano Caruso and ESOI Young ...
19/11/2025

It is a busy season for ESOI President Melvin D'Anastasi, ESOI Membership Committee Chair Damiano Caruso and ESOI Young Radiologists Committee Chair Giovanni Cappello, who — right after — are already on an important mission representing ESOI - European Society of Oncologic Imaging at the in Brussels, Belgium.

The summit is organised by the European Cancer Organisation, the largest non-profit, multi-professional federation in the European cancer community, bringing together hundreds of professional societies and patient groups to advocate for more effective, efficient, and equitable cancer care.

They are joined by Ola Stankiewicz (European Society of Urogenital Radiology), Paola Clauser (Eusobi - European Society of Breast Imaging), Annemiek Snoeckx (myESR), Mario Silva (European Society of Thoracic Imaging) and Isabelle De K**k (ESGAR - European Society of Gastrointestinal and Abdominal Radiology).

🎉 And that’s a wrap on  !Our final congress day delivered a strong programme with four parallel morning workshops, follo...
18/11/2025

🎉 And that’s a wrap on !

Our final congress day delivered a strong programme with four parallel morning workshops, followed by sessions on Prostate Cancer, Atypical Metastases, and Technological Advances in Oncologic Imaging, before concluding with the official closing and awards ceremony.

A heartfelt thank you to our outstanding faculty members, wonderful participants, and generous sponsors for their commitment and support throughout the event — your contributions were essential in making this year’s congress a true success!

We look forward to welcoming you all next year in Heidelberg! 🇩🇪✨

✨ Day 2 at   — another inspiring day of learning and collaboration!Friday brought a strong mix of expert sessions, multi...
15/11/2025

✨ Day 2 at — another inspiring day of learning and collaboration!

Friday brought a strong mix of expert sessions, multidisciplinary discussions, and practical training. Highlights included the Breast MDT, the Peritoneal Carcinomatosis session, as well as the block on Novel Developments in Oncologic Imaging.

The afternoon continued with the Head & Neck MDT Simulation and a session dedicated to European AI collaboration through the EUCAIM platform.

The day concluded with four parallel workshops, offering participants the opportunity to refine their skills across key areas of oncologic imaging.

💡 What an inspiring start to  !The day opened with a warm welcome from Congress President Melvin D'Anastasi and Jo Etien...
13/11/2025

💡 What an inspiring start to !

The day opened with a warm welcome from Congress President Melvin D'Anastasi and Jo Etienne Abela, Malta’s Minister for Health and Active Ageing, followed by an inspiring ESOI meets ESR PAG session on Radiologist-Patient Communication and Patient-Centred Oncology Care.

🔬 Highlights of the day included the Pancreatic MDT Simulation, a keynote lecture by Hedvig Hricak on Global Health, and sessions on Haematological Malignancies, as well as workshops on Patient Communication, Therapy Complications, Errors in Oncologic Imaging, and Lung Cancer Staging.

The day ended with innovative scientific sessions and a Poster Walking Tour — setting the tone for an exciting congress ahead!

Come see Gleamer’s booth during the   and learn about their mission to pioneer the future of medical imaging.Gleamer is ...
11/11/2025

Come see Gleamer’s booth during the and learn about their mission to pioneer the future of medical imaging.

Gleamer is revolutionizing medical imaging with a cutting-edge AI copilot. By combining the expertise of both clinical and AI specialists, Gleamer develops high-performing, easy-to-integrate radiology AI solutions that enhance diagnostic accuracy and patient care. With more than 2,500 healthcare institutions equipped worldwide, 100+ clinical studies and over 40 million exams analyzed each year, Gleamer has become a trusted partner in the daily practice of diagnostic imaging.

After transforming musculoskeletal and chest X-ray interpretation, Gleamer is now extending its expertise to oncologic imaging on CT, where precision and early detection are key, with two innovative solutions:

• BoneCT - detecting secondary bone lesions with precision

Early and accurate detection of secondary bone lesions is critical - yet many small lesions go unnoticed on manual CT reviews leading to delayed treatment and increased healthcare costs. BoneCT brings AI-driven rigor to the bone-window, turning a tedious task into a streamlined, reliable process.

• LungCT - AI support for thoracic oncology

Radiology departments face skyrocketing CT volumes and literature shows many new pulmonary nodules are missed on baseline CT, straining resources and patient care. LungCT reduces variability, speeds up reads, and ensures that no high-risk lesion slips through the cracks - so your team can focus on early intervention and better patient outcomes.

Alongside these CT innovations, Gleamer’s CE-marked and FDA-cleared AI for chest X-ray –ChestView, supports the identification of multiple pathologies including nodules on chest X-rays.

Together, BoneCT, LungCT and ChestView form a unified ecosystem dedicated to AI-assisted oncology imaging. By combining validated accuracy, workflow integration, and interpretability, Gleamer empowers radiologists to deliver more confident diagnoses and better patient outcomes across the continuum of oncology care.

🌍 LMVP Telemedicine | Supporting Imaging Excellence at   At LMVP Telemedicine, we’re proud to support the spirit of inno...
10/11/2025

🌍 LMVP Telemedicine | Supporting Imaging Excellence at

At LMVP Telemedicine, we’re proud to support the spirit of innovation, collaboration, and excellence that defines ESOI Touchdown 2025 Malta, hosted by the European Society of Oncologic Imaging. As Europe’s oncologic imaging community comes together to advance diagnostic innovation and knowledge exchange, LMVP continues to champion the same principles that drive ESOI — improving outcomes through clinical excellence, transparency, and technology-led transformation.



🔬 About LMVP Telemedicine

Founded by Dr Lorenzo Mannelli, LMVP delivers subspecialist teleradiology services across the UK, Ireland, and Europe. Our network of more than 60 GMC and IMC-registered consultant radiologists provides advanced reporting across Oncology, Cardiac, Neuro, MSK, and Paediatric Imaging, all supported by an ISO-certified governance framework. Powered by the OnePacs platform, LMVP integrates AI-driven triage, structured reporting, peer-review quality assurance, and GDPR-secure cloud infrastructure — enabling healthcare providers to deliver faster, more accurate, and safer diagnostics for patients.



💡 Our Commitment

We share ESOI’s vision for a connected imaging community where collaboration and digital innovation reduce diagnostic inequalities and improve patient care.

Through investment in technology, training, and international partnerships, LMVP continues to:

• Enhance subspecialist access for complex oncology and cardiac imaging

• Support clinical teams with transparent, ISO-aligned governance

• Leverage AI and workflow automation to reduce turnaround times

• Strengthen clinical quality through 10% double-reading and continuous audit cycles



🌐 Transforming Radiology Across Borders

From National Health Systems to Private partnerships, LMVP enables scalable, secure teleradiology that unites clinicians across geographies. Our work embodies ESOI’s goals — advancing diagnostic excellence and building sustainable imaging networks that deliver measurable value to healthcare systems and patients.



🔗 Discover more: www.lmvptelemedicine.com



💬 Join the conversation:

Founded by Radiologists for Radiologists. A group of diagnostic imaging experts, providing bespoke and cost-efficient services without compromising quality.

🔬 First case from the Atypical Liver Metastases collection, prepared by Prof. Chandan Kakkar, Dayanand Medical College a...
07/11/2025

🔬 First case from the Atypical Liver Metastases collection, prepared by Prof. Chandan Kakkar, Dayanand Medical College and Hospital, Ludhiana, Punjab, India.

Better ways to assess treatment response in oncology imaging 🔍Size alone doesn’t tell the whole story.✅ Always compare w...
28/10/2025

Better ways to assess treatment response in oncology imaging 🔍

Size alone doesn’t tell the whole story.
✅ Always compare with the baseline
💊 Consider treatment effects
🧠 Look at structural changes, not just measurements

Understanding and applying key principles from RECIST and RANO can make your evaluations more accurate and clinically meaningful.

👉 Follow us for more clear, practical insights in

💬 Communicating bad news — one of the hardest moments in a radiologist’s career.Many radiologists have faced that situat...
14/10/2025

💬 Communicating bad news — one of the hardest moments in a radiologist’s career.

Many radiologists have faced that situation: a patient asks a question that catches the doctor off guard. The way the response is delivered can shape the patient’s entire experience.

Join us at the upcoming ESOI Touchdown Malta (November 13–15, 2025) for a powerful workshop: “Patient communication: breaking bad news”, organised in collaboration with the ESR Patient Advisory Group.

Through real-life scenarios and expert insights, we’ll explore how radiologists can build empathy, confidence, and clarity when it matters most.

📚 Recommended Reading Ahead of Our Upcoming Webinar: "Accurate imaging diagnosis and treatment decision of HCC". Prepare...
13/10/2025

📚 Recommended Reading Ahead of Our Upcoming Webinar: "Accurate imaging diagnosis and treatment decision of HCC". Prepare for an insightful session by reviewing these key articles:

👉 Article: Imaging Diagnosis of Hepatocellular Carcinoma: A State-of-the-Art Review.
Available at: https://doi.org/10.3390/diagnostics13040625

👉 Article: Pathologic, Molecular, and Prognostic Radiologic Features of Hepatocellular Carcinoma.
Available at: https://doi.org/10.1148/rg.2021210009

👉 Article: Imaging for the Diagnosis of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Available at: https://doi.org/10.1002/hep.29487

👉 Article: AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.
Available at: https://journals.lww.com/hep/fulltext/2023/12000/aasld_practice_guidance_on_prevention,_diagnosis,.27.aspx

Webinar: Accurate imaging diagnosis and treatment decision of HCC
📅 Wednesday, October 15, 13:00 CEST
Speaker: Chuanmiao Xie, Guangzhou/CN
Moderator: Evangelos Chartampilas, Athens/GR

🎓 Participants will earn 1 European CME credit (ECMEC®) accredited by the European Accreditation Council for Continuing Medical Education (EACCME®).

🔗 More details: https://www.esoi-society.org/webinars/
👉 Register here: https://us06web.zoom.us/webinar/register/8317398082792/WN_ckNXOYSNTWyihEh4C0zouA

✨ Great news!ESOI Touchdown 2025 Malta has been officially accredited by EACCME® with 16.5 European CME credits (ECMEC®)...
30/09/2025

✨ Great news!
ESOI Touchdown 2025 Malta has been officially accredited by EACCME® with 16.5 European CME credits (ECMEC®).

3 days of the latest insights into cutting-edge oncologic imaging applications! Meet world-renowned experts, learn more about the current best clinical practice and explore the future developments in oncologic imaging.

🔎 Curious about our programme? Take a look here: https://www.esoi-society.org/events/

🎟️ Haven’t registered yet? Secure your spot now: https://my.weezevent.com/esoi-touchdown-2025-malta

We look forward to welcoming you to Malta very soon!

Adresse

Am Gestade 1
Wien
1010

Öffnungszeiten

Montag 09:00 - 17:00
Dienstag 09:00 - 17:00
Mittwoch 09:00 - 17:00
Donnerstag 09:00 - 17:00
Freitag 09:00 - 15:30

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von ESOI - European Society of Oncologic Imaging erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Die Praxis Kontaktieren

Nachricht an ESOI - European Society of Oncologic Imaging senden:

Teilen

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

The main goal of the society is to raise the scientific level and professional knowledge within the field of oncologic imaging and has thereby two important missions. First, the society strives to globally provide high-quality education in cancer imaging and research - not only in countries with but also in those without access to high quality oncological education. Second, ESOI aims to become an oncologic imaging society that will attract not only radiologists but everyone working in the field of oncology. There is no doubt that for an optimal treatment outcome the input of radiologists in the multidisciplinary approach is crucial. Furthermore, it will be more important than ever to understand the questions from our oncological clinical partners, which are increasingly complex. ESOI recognises these needs and strives to create an international platform that will bring together radiologists with clinical professionals such as surgical oncologists, medical oncologists, radiation oncologists and basic scientists in immunology, genetics, molecular pathology, biotechnology etc. The ESOI board and I would very much welcome you as our colleague who would like to participate or be involved in ESOI’s activities and contribute to the exciting new developments in oncologic imaging.

Prof. Dr. Regina Beets-Tan on behalf of the ESOI Executive Committee